David A. Siegel Codexis, Inc. Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Codexis, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 867,700 shares of CDXS stock, worth $2.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

867,700

Previous 934,800 7.18%

Holding current value

$2.93 Million

Previous $2.85 Million 6.21%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.59 - $4.65 $173,789 - $312,015	-67,100 Reduced 7.18%	867,700 $3.03 Million
Q4 2023 Feb 14, 2024	SELL	$1.54 - $3.37 $363,748 - $795,994	-236,200 Reduced 20.17%	934,800 $2.85 Million
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.75 $196,650 - $491,625	-131,100 Reduced 10.07%	1,171,000 $2.21 Million
Q2 2023 Aug 14, 2023	BUY	$2.21 - $4.43 $633,165 - $1.27 Million	286,500 Added 28.21%	1,302,100 $3.65 Million
Q1 2023 May 15, 2023	SELL	$3.81 - $6.76 $376,047 - $667,212	-98,700 Reduced 8.86%	1,015,600 $4.2 Million

Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $1.47 Million - $2.36 Million	345,700 Added 44.98%	1,114,300 $5.19 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $277,548 - $588,988	45,800 Added 6.34%	768,600 $4.66 Million
Q2 2022 Aug 15, 2022	BUY	$8.35 - $21.89 $2.52 Million - $6.61 Million	301,800 Added 71.69%	722,800 $7.56 Million
Q1 2022 May 16, 2022	SELL	$16.97 - $31.93 $739,892 - $1.39 Million	-43,600 Reduced 9.38%	421,000 $8.68 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $41.78 $3.96 Million - $6.46 Million	154,700 Added 49.92%	464,600 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $19,650 - $27,990	1,000 Added 0.32%	309,900 $7.21 Million
Q2 2021 Aug 16, 2021	BUY	$17.48 - $25.46 $2.5 Million - $3.64 Million	142,800 Added 85.97%	308,900 $7 Million
Q1 2021 May 17, 2021	BUY	$18.08 - $28.8 $2.82 Million - $4.5 Million	156,200 Added 1577.78%	166,100 $3.8 Million
Q4 2020 Feb 16, 2021	SELL	$11.7 - $23.41 $18,720 - $37,456	-1,600 Reduced 13.91%	9,900 $216,000
Q3 2020 Nov 16, 2020	BUY	$11.21 - $13.82 $128,915 - $158,930	11,500 New	11,500 $135,000
Q3 2019 Nov 14, 2019	SELL	$12.75 - $19.01 $285,600 - $425,824	-22,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$17.0 - $21.88 $380,800 - $490,112	22,400 New	22,400 $413,000
Q4 2018 Feb 14, 2019	SELL	$14.06 - $22.57 $222,148 - $356,606	-15,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.35 - $19.1 $41,385 - $59,210	-3,100 Reduced 16.4%	15,800 $271,000
Q2 2018 Aug 14, 2018	BUY	$10.35 - $16.45 $195,615 - $310,905	18,900 New	18,900 $272,000

Others Institutions Holding CDXS

# of Institutions

131

Shares Held

49.5M

Call Options Held

33.4K

Put Options Held

21K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $221M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account